Dr. Azizah Mainal is an Associate Professor at the Department of Chemistry, Faculty of Science, Universiti Malaya.  She has been teaching physical chemistry courses at the department since 2007.  Her research interest is on liquid crystals which started with the studies on field-induced liquid crystal director alignment to presently, on the stability of naturally occurring liquid crystals. Her other interest is on science communication, and she was the editor of CONNECT, the first Faculty of Science’s newsletter (2017-2019.) She is currently a member of SEMARAK, a platform formed at the Faculty of Science to inform, excite, and influence the university community and the mass via various science communication activities. She also forms Artify Science which is a gathering of literature and art enthusiasts sharing their readings, creative writings, poetry, songs, paintings and, etc.

Sabyasachi Das has obtained his Ph. D degree from Vidyasagar University, India in 2015 in collaboration with Indian Institute of Technology (IIT), Kharagpur. He clinched 3rd position in M. Sc in Human Physiology with specialization in Microbiology and Immunology from Vidyasagar University in 2009.  He was also recipient of “Genetic Biotechnology, Senior research fellowship” from Council of Scientific and Industrial Research (CSIR), Govt. of India in 2013 and awarded JRF from Department of Biotechnology (DBT), Govt of India in 2009. After Ph D. he has completed two postdoctoral research from Calcutta School of Tropical Medicine, India in 2017. In the same year he joined as a guest faculty of molecular biology and immunology in Vidyasagar University. Furthermore, he joined department of Physiology, Lincoln University College Malaysia as senior lecture in 2018 where he became HOD of Physiology in 2019. In early 2021, he joined as an assistant professor of department of Physiology, Manipal University College Malaysia. Subsequently, in 2024 he joined department of Physiology, Faculty of Medicine, University Malaya as senior lecturer. His field of research are broadly on infectious disease, malaria, cancer, host immune interaction, nano drug delivery and development of early detection kit. He has extensively worked on molecular epidemiology and drug resistant pattern of Plasmodium. falciparum in different endemic zones of India. He has widely worked on understanding of chloroquine, and sulfadoxine-pyrimethamine resistance in P. falciparum and P. vivax. He was the first person to identify the failing of artemisinin combination therapy efficacy in eastern India and found the evidence of emergence of partial artemisinin resistant P. falciparum, thereby established a novel validate marker of artemisinin resistance. He has also extensively worked on nano mediated drug delivery against, parasite, bacteria and cancer cells. He has also developed novel early detection kit for malaria and dengue. He has also worked widely on immunity after covid vaccination.  Till date he has published more than 30 international research articles in different reputed journals including New England Journal of Medicine, Clinical infectious disease, International J of Antimicrobial Agent, Antimicrobial Agent and Chemotherapy, International J Parasitology: drug and drug resistance, International J of Pharmaceutics, Journal of biological macromolecule, European J of Pharmacology, Journal of Biological Inorganic Chemistry. He has one granted Malaysian Patent and filed one Indian Patent. He received prestigious INSA (Indian National Science Academy) Medal for Young Scientists for the year 2022 in health science (India’s highest recognition of promise, creativity and excellence in a young scientist). He also awarded “Young Scientist Award” in ‘Medical Science including Physiology’ by Indian Science Congress Association in 2017 for his commendable work in “Drug resistance malaria and nano drug development”. He has involved in different teaching activities for the students of different programs in University Malaya such as Bachelor of Biomedical Science, Bachelor of Medicine, Bachelor of Surgery (MBBS), and Bachelor of Dental Surgery. In his previous working place (MUCM) he was working as a Director of Research Management Centre (RMC) as well coordinator of mentor student project (MSB) for MBBS. He is the member of Royal Society of Biology (London). He is also the member of Malaysian Society of Pharmacology and Physiology (MSPP). He is also life member of The Physiological Society of Indian.

Prof. Ali Mohammad Sharifi is a scholar with over 27 years of experience in Molecular Pharmacology at the Iran University of Medical Sciences and currently joined as a professor of regenerative Medicine in the Tissue Engineering Group at NOCERAL, department of Orthopedics Surgery, School of Medicine. He obtained his Ph.D. from the University of Glasgow in 1992 and in 2018, he further enriched his expertise by acquiring a Tissue Banking Diploma from the National University of Singapore. Throughout his career, Prof. Sharifi has undertaken international research, including working at McGill University in Canada and at Max Plank Institute in Germany. His research output includes over 100 publications in high-impact journals, along with several patented innovations. He has held various administrative and editorial roles in academia, and has served as a peer reviewer for numerous high-impact journals. His dedication to education is evident through his mentorship of undergraduate and postgraduate students, particularly Ph.D. candidates specializing in molecular medicine, tissue engineering, molecular pharmacology, and cell therapy.  Prof. Sharifi's research expertise involves the fields of cell therapy and regenerative Pharmacology, with a particular emphasis on translational medicine. His extensive body of work includes pioneering studies on pharmacological priming, therapeutic angiogenesis, and innovative strategies to enhance the effectiveness of stem cell therapy by manipulating HIF-1α stabilization, especially in the context of diabetes. Additionally, his research activities include bone and cartilage regeneration, employing a diverse array of strategies such as stem cells and biologically derived products like amniotic membrane extract and mesenchymal stem cell-derived secretome. He has also explored the potential of herbal agents in regenerative medicine.  His contributions extend to the development of custom-made bio-implants for addressing large bone defects and the design and production of various wound dressings, with a specific focus on diabetic wound healing. In recent times, Prof. Sharifi has harnessed the transformative power of CRISPR gene editing technology to combat synovial fibrosis induced by osteoarthritis. In summary, Professor Sharifi is an active scientist in the field of Molecular Pharmacology and Regenerative Medicine, exemplifying innovation, and dedication to advancing scientific knowledge for improvement of healthcare and human well-being.